Polycystic ovary syndrome

Endocrinology and Metabolism Clinics of North America

Volumn 26, Issue 4, 1997, Pages 893-912

  Goudas, V T ^a   Dumesic, D A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; CYPROTERONE ACETATE; DESOGESTREL PLUS ETHINYLESTRADIOL; DEXAMETHASONE; ETHINYLESTRADIOL PLUS NORGESTIMATE; FINASTERIDE; FLUTAMIDE; HUMAN MENOPAUSAL GONADOTROPIN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; SPIRONOLACTONE;

ANOVULATION; CLINICAL FEATURE; COMORBIDITY; FEMALE; HIRSUTISM; HORMONAL THERAPY; HUMAN; HYPERANDROGENISM; LUTEINIZING HORMONE RELEASE; MENSTRUAL IRREGULARITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARIECTOMY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0030700846     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70286-3     Document Type: Article

References (55)

1. J. Adams D.W. Polson S. Franks Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism BMJ 293 1986 355
2. R. Azziz H.A. Zacur Polycystic ovary syndrome E.E. Wallach H.A. Zacur Reproductive Medicine and Surgery 1995 Mosby St. Louis 230
3. R. Barbieri Hyperandrogenism E.E. Wallach H.A. Zacur Reproductive Medicine and Surgery 1995 Mosby St. Louis 209
4. R.L. Barbieri The role of adipose tissue and hyperinsulinemia in the development of hyperandrogenism in women M.L. L'Hermite Progress in Reproductive Biology and Medicine vol 14 1990 Karger Basel
5. R.B. Barnes R.L. Rosenfield D.A. Ehrmann Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: Evidence for perinatal masculinization of neuroendocrine function in women J Clin Endocrinol Metab 79 1994 1328
6. F. Benjamin S. Deutsch H. Saperstein Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease Fertil Steril 46 1986 215
7. R.P. Buyalos Insulin-like growth factors: Clinical experience in ovarian function Am J Med 98 S1A 1995 55S
8. E. Carmina T. Koyama L. Chang Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167 1992 1807
9. E. Carmina F. Rosato M. Maggiore Prolactin secretion in polycystic ovary syndrome (PCO): Correlation with the steroid pattern Acta Endocrinol (Copenh) 105 1984 99
10. M.B. Davidson Diabetes Mellitus: Diagnosis and Treatment ed 2 1991 Churchill Livingstone New York
11. J. Derksen S.K. Nagesser A.E. Meinders Identification of virilizing adrenal tumors in hirsute women N Engl J Med 331 1994 968
12. D. Dewailly Y. Robert I. Helin Ovarian stromal hypertrophy in hyperandrogenic women Clin Endocrinol 41 1994 557
13. D. Dewailly M.C. Vantyghem-Haudiquet C. Sainsard Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency J Clin Endocrinol Metab 63 1986 418
14. D.A. Dumesic D.H. Abbott J.R. Eisner Prenatal exposure of female Rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood Fertil Steril 67 1997 155
15. A. Dunaif Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non–insulin-dependent diabetes mellitus Am J Med 98 1A 1995 33S
16. A. Dunaif G. Green R.G. Phelps Acanthosis nigricans, insulin action, and hyperandrogenism: Clinical, histological, and biochemical findings J Clin Endocrinol Metab 73 1991 590
17. A. Dunaif D. Scott D. Finegood The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome J Clin Endocrinol Metab 81 1996 3299
18. A. Dunaif K.R. Segal D.R. Shelley Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome Diabetes 41 1992 1257
19. D.A. Ehrmann R.B. Barnes R.L. Rosenfield Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion Endocr Rev 16 1995 322
20. D.A. Ehrmann R.L. Rosenfield R.B. Barnes Detection of functional ovarian hyperandrogenism in women with androgen excess N Engl J Med 327 1992 157
21. G.F. Erickson V.G. Garzo D.A. Magoffin Insulin-like growth factor–I regulates aromatase activity in human granulosa and granulosa luteal cells J Clin Endocrinol Metab 69 1989 716
22. G.F. Erickson D.A. Magoffin J.R. Cragun The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries J Clin Endocrinol Metab 70 1990 894
23. D.C. Farhi J. Nosanchuk S.G. Silverberg Endometrial adenocarcinoma in women under 25 years of age Obstet Gynecol 68 1986 741
24. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853
25. C.I. Friedman G.E. Schmidt M.H. Kim Serum testosterone concentrations in the evaluation of androgen-producing tumors Am J Obstet Gynecol 153 1985 44
26. G.R. Fulcher M. Walker K.G.M.M. Alberti The assessment of insulin action in vivo K.G.M.M. Alberti R.A. DeFronzo H. Keen P. Zimmet International Textbook of Diabetes Mellitus 1992 John Wiley & Sons New York 513
27. L.C. Giudice Insulin-like growth factors and ovarian follicular development Endocr Rev 13 1992 641
28. L.C. Giudice The insulin-like growth factor system in normal and abnormal human ovarian follicle development Am J Med 98 S1A 1995 48S
29. D.I. Hoffman K. Klove R.A. Lobo The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women Fertil Steril 42 1984 76
30. D.J. Jacubowicz J.E. Nestler 17{alpha}hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss J Clin Endocrinol Metab 82 1997 556
31. M.D. Jensen M.W. Haymond R.A. Rizza Influence of body fat distribution on free fatty acid metabolism in obesity J Clin Invest 83 1989 1168
32. R.S. Legro The genetics of polycystic ovary syndrome Am J Med 98 S1A 1995 9
33. R.A. Lobo Ovarian hyperandrogenism and androgen-producing tumors Endocrinol Metab Clin North Am 20 1991 773
34. G.B. Maroulis G.E. Abraham Diagnostic tests in hirsutism V.B. Mahesh R.B. Greenblatt Hirsutism and Virilism: Pathogenesis, Diagnosis and Management 1983 John Wright PSG Boston 295
35. D.R. Meldrum G.E. Abraham Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors Obstet Gynecol 53 1979 36
36. J.E. Nestler C.O. Barlascini D.W. Matt Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome J Clin Endocrinol Metabol 68 1989 1027
37. R. Pasquali D. Antenucci F. Casimirri Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss J Clin Endocrinol Metab 68 1989 173
38. D.E. Pittaway Neoplastic causes of hyperandrogenism Infertil Reprod Med Clin North Am 2 1991 531
39. D.W. Polson J. Adams J. Wadsworth Polycystic ovaries—a common finding in normal women Lancet 1 1988 870
40. L. Poretsky B. Piper Insulin resistance, hypersecretion of LH and a dual defect hypothesis for the pathogenesis of polycystic ovary syndrome Obstet Gynecol 84 1994 613
41. R.W. Rebar H.L. Judd S.S. Yen Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome J Clin Invest 57 1976 1320
42. R.W. Rebar Gonadotropin secretion in polycystic ovary disease Semin Reprod Endocrinol 23 1984 223
43. M. Rebuffe-Scrive G. Cullberg P.A. Lundberg Anthropometric variables and metabolism in polycystic ovarian disease Horm Metab Res 21 1989 391
44. R.A. Rittmaster Medical treatment of androgen dependent hirsutism J Clin Endocrinol Metab 80 1995 2559
45. R.L. Rosenfield R.B. Barnes J.F. Cara Dysregulation of cytochrome P450c17a as the cause of polycystic ovarian syndrome Fertil Steril 53 1990 785
46. L.B. Schwartz M.P. Diamond The coexistence of hyperandrogenism and hyperinsulinemia: A relationship between reproductive function and carbohydrate metabolism Infertil Reprod Med Clin North Am 2 1991 611
47. J. Smitz M. Camus P. Devroey Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist HMG superovulation for in vitro fertilization Hum Reprod 5 1990 933
48. L. Speroff R.H. Glass N.G. Kase Clinical Gynecologic Endocrinology and Infertility ed 5 1994 Williams & Wilkins Baltimore
49. I.F. Stein M.L. Leventhal Amenorrhea associated with bilateral polycystic ovaries Am J Obstet Gynecol 29 1935 181
50. L. Taylor J.W.T. Ayers M.D. Gross Diagnostic considerations in virilization: Iodomethyl-norcholesterol scanning in the localization of androgen secreting tumors Fertil Steril 46 1986 1005
51. R.A. Wild Hyperandrogenism: Implications for cardiovascular, endometrial, and breast disease E.Y. Adashi J.A. Rock Z. Rosenwaks Reproductive Endocrinology, Surgery, and Technology 1996 Lippincott-Raven Philadelphia 1617
52. R.A. Wild P. Alaupovic I.J. Parker Lipid and apolipoprotein abnormalities in hirsute women: The association with insulin resistance Am J Obstet Gynecol 166 1992 1191
53. R.A. Wild E.S. Umstot R.N. Andersen Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism Am J Obstet Gynecol 146 1984 602
54. S.S.C. Yen Chronic anovulation caused by peripheral endocrine disorders S.S.C. Yen R.B. Jaffe Reproductive Endocrinology ed 3 1991 WB Saunders Philadelphia 576
55. B. Zumoff R. Freeman S. Coupey A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with polycystic-ovary syndrome N Engl J Med 309 1983 1206